Literature DB >> 17035305

Examination of a fusogenic hexameric core from human metapneumovirus and identification of a potent synthetic peptide inhibitor from the heptad repeat 1 region.

Scott A Miller1, Sharon Tollefson, James E Crowe, John V Williams, David W Wright.   

Abstract

Paramyxoviruses are a leading cause of childhood illness worldwide. A recently discovered paramyxovirus, human metapneumovirus (hMPV), has been studied by our group in order to determine the structural relevance of its fusion (F) protein to other well-characterized viruses utilizing type I integral membrane proteins as fusion aids. Sequence analysis and homology models suggested the presence of requisite heptad repeat (HR) regions. Synthetic peptides from HR regions 1 and 2 (HR-1 and -2, respectively) were induced to form a thermostable (melting temperature, approximately 90 degrees C) helical structure consistent in mass with a hexameric coiled coil. Inhibitory studies of hMPV HR-1 and -2 indicated that the synthetic HR-1 peptide was a significant fusion inhibitor with a 50% inhibitory concentration and a 50% effective concentration of approximately 50 nM. Many viral fusion proteins are type I integral membrane proteins utilizing the formation of a hexameric coiled coil of HR peptides as a major driving force for fusion. Our studies provide evidence that hMPV also uses a coiled-coil structure as a major player in the fusion process. Additionally, viral HR-1 peptide sequences may need further investigation as potent fusion inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035305      PMCID: PMC1797239          DOI: 10.1128/JVI.01243-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion.

Authors:  C J Russell; T S Jardetzky; R A Lamb
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

2.  Short constrained peptides that inhibit HIV-1 entry.

Authors:  Samuel K Sia; Peter A Carr; Andrea G Cochran; Vladimir N Malashkevich; Peter S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

3.  Design of a protein surface antagonist based on alpha-helix mimicry: inhibition of gp41 assembly and viral fusion.

Authors:  Justin T Ernst; Olaf Kutzki; Asim K Debnath; Shibo Jiang; Hong Lu; Andrew D Hamilton
Journal:  Angew Chem Int Ed Engl       Date:  2002-01-18       Impact factor: 15.336

4.  Amino acid substitution matrices from protein blocks.

Authors:  S Henikoff; J G Henikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

5.  Analysis of the genomic sequence of a human metapneumovirus.

Authors:  Bernadette G van den Hoogen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Virology       Date:  2002-03-30       Impact factor: 3.616

Review 6.  The modelling of drug response.

Authors:  B Whiting; A W Kelman
Journal:  Clin Sci (Lond)       Date:  1980-11       Impact factor: 6.124

7.  Human metapneumovirus infections in young and elderly adults.

Authors:  Ann R Falsey; Dean Erdman; Larry J Anderson; Edward E Walsh
Journal:  J Infect Dis       Date:  2003-02-24       Impact factor: 5.226

8.  Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion.

Authors:  Enxiu Wang; Xiao'ou Sun; Yuan Qian; Linqing Zhao; Po Tien; George F Gao
Journal:  Biochem Biophys Res Commun       Date:  2003-03-14       Impact factor: 3.575

9.  A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.

Authors:  C Wild; T Oas; C McDanal; D Bolognesi; T Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children.

Authors:  John V Williams; Paul A Harris; Sharon J Tollefson; Lisa L Halburnt-Rush; Joyce M Pingsterhaus; Kathryn M Edwards; Peter F Wright; James E Crowe
Journal:  N Engl J Med       Date:  2004-01-29       Impact factor: 91.245

View more
  17 in total

1.  Residues of the human metapneumovirus fusion (F) protein critical for its strain-related fusion phenotype: implications for the virus replication cycle.

Authors:  Vicente Mas; Sander Herfst; Albert D M E Osterhaus; Ron A M Fouchier; José A Melero
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 2.  New Approaches for Immunization and Therapy against Human Metapneumovirus.

Authors:  Sherry C Wen; John V Williams
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

3.  HRA2pl peptide: a fusion inhibitor for human metapneumovirus produced in tobacco plants by transient transformation.

Authors:  Verónica A Márquez-Escobar; Rocío Tirado-Mendoza; Daniel E Noyola; Abel Gutiérrez-Ortega; Ángel G Alpuche-Solís
Journal:  Planta       Date:  2015-04-01       Impact factor: 4.116

Review 4.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

5.  Genomic analysis of four human metapneumovirus prototypes.

Authors:  Rohith Piyaratna; Sharon J Tollefson; John V Williams
Journal:  Virus Res       Date:  2011-06-28       Impact factor: 3.303

6.  Human metapneumovirus G protein is highly conserved within but not between genetic lineages.

Authors:  Chin-Fen Yang; Chiaoyin K Wang; Sharon J Tollefson; Linda D Lintao; Alexis Liem; Marla Chu; John V Williams
Journal:  Arch Virol       Date:  2013-02-06       Impact factor: 2.574

7.  Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein.

Authors:  Dirk Roymans; Hendrik L De Bondt; Eric Arnoult; Peggy Geluykens; Tom Gevers; Marcia Van Ginderen; Nick Verheyen; Hidong Kim; Rudy Willebrords; Jean-François Bonfanti; Wouter Bruinzeel; Maxwell D Cummings; Herman van Vlijmen; Koen Andries
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

8.  Human metapneumovirus small hydrophobic (SH) protein downregulates type I IFN pathway signaling by affecting STAT1 expression and phosphorylation.

Authors:  Andrew K Hastings; Katherine R Amato; Sherry C Wen; Laura S Peterson; John V Williams
Journal:  Virology       Date:  2016-04-27       Impact factor: 3.616

9.  Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.

Authors:  Céline Deffrasnes; Marie-Eve Hamelin; Gregory A Prince; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

10.  Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years.

Authors:  Chin-Fen Yang; Chiaoyin K Wang; Sharon J Tollefson; Rohith Piyaratna; Linda D Lintao; Marla Chu; Alexis Liem; Mary Mark; Richard R Spaete; James E Crowe; John V Williams
Journal:  Virol J       Date:  2009-09-09       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.